| Name | Pataxel |
| Description | Paclitaxel is an antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilises microtubules by preventing depolymerisation. This stability inhibits the normal dynamic reorganisation of the microtubule network, which is essential for vital interphase and mitotic cellular functions. In addition, paclitaxel induces abnormal arrays or bundles of microtubules throughout the cell cycle and multiple asters of microtubules during mitosis. |
| Active Ingredient | Paclitaxel |
| Indication |
Paclitaxel in combination therapy is indicated for:
|
| Strengths | 30mg, 100mg & 300mg injection vial |
| Business Partner | Mylan S.A.S |
| Origin | France |